Top compounds associated with response to RFXANK


Feature Type Standardized
Nominal ANOVA
mRNA tamatinib CTRPv2 pan-cancer AAC 0.024 0.5
mRNA Doxorubicin gCSI pan-cancer AAC 0.031 0.5
mRNA tanespimycin:bortezomib (250:1 mol/mol) CTRPv2 pan-cancer AAC -0.024 0.5
mRNA JQ-1:navitoclax (2:1 mol/mol) CTRPv2 pan-cancer AAC -0.022 0.5
mRNA KU-55933 GDSC1000 pan-cancer AAC -0.022 0.6
mRNA paclitaxel CTRPv2 pan-cancer AAC 0.021 0.6
mRNA ML210 CTRPv2 pan-cancer AAC 0.021 0.6
mRNA PD 153035 CTRPv2 pan-cancer AAC -0.027 0.6
mRNA Erlotinib UHNBreast pan-cancer AAC -0.17 0.6
mRNA CI-976 CTRPv2 pan-cancer AAC 0.024 0.6
Download CSV